Paper Details
- Home
- Paper Details
Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates: implications for senolytic clinical trial design.
Author: BlawasMegan, ChenHaiying, DaySteven M, DeStephanisDarla, JusticeJamie N, KavanaghKylie, LongMasha, MacauleyShannon L, RuggieroAlistaire D, VemuriRavichandra, WilliamsAbigail G
Original Abstract of the Article :
Cellular senescence increases with aging and results in secretion of pro-inflammatory factors that induce local and systemic tissue dysfunction. We conducted the first preclinical trial in a relevant middle-aged nonhuman primate (NHP) model to allow estimation of the main translatable effects of the...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643765/
データ提供:米国国立医学図書館(NLM)
Senolytics: A New Oasis in the Desert of Aging
The desert of aging is a vast and unforgiving landscape, marked by the inevitable decline of cellular function. This research explores the potential of [senolytic] therapy to combat the effects of aging, focusing on the combined effects of [dasatinib and quercetin] in a preclinical trial using [nonhuman primates]. It's like a camel seeking a remedy for the harsh conditions of the desert, hoping to rejuvenate and restore vitality.
Senolytics: A Potential Oasis in the Desert of Cellular Senescence
The study reveals that dasatinib and quercetin, when administered together, showed promise in reducing [senescence marker gene expressions] and improving [immune cell profiles] in nonhuman primates. It's like discovering a hidden oasis in the desert, offering a potential solution to the challenges of aging. The researchers found that this combination therapy also had a positive impact on [blood urea nitrogen and glycosylated hemoglobin A1c], suggesting potential benefits for metabolic health.
A Path to Rejuvenation: Exploring Senolytics for Aging
This research offers a glimmer of hope in the desert of aging. Senolytic therapies, like dasatinib and quercetin, may hold the key to combating the effects of cellular senescence and improving overall health. It's like finding a well-marked path through the desert, leading towards a more fulfilling and healthy life. The study provides a compelling argument for further investigation into senolytic therapies as potential anti-aging interventions.
Dr.Camel's Conclusion
This preclinical trial offers exciting insights into the potential of senolytic therapy to combat the effects of aging. The combination of dasatinib and quercetin showed promising results in reducing senescence marker gene expressions, improving immune cell profiles, and potentially enhancing metabolic health. It's like a camel discovering a new oasis in the vast desert of aging, offering a path towards a more vibrant and youthful future. This research represents a significant step forward in the exploration of senolytic therapies as potential anti-aging interventions.
Date :
- Date Completed 2023-11-15
- Date Revised 2023-11-16
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.